They tend to be gastrointestinal in nature, since thats where the medication is primarily working, and are usually temporary, says Kushner
The Ongoing Debate: Concerns About Pediatric GLP-1 Use Critics raise several significant concerns: Growth and Development: Impact during crucial developmental years Hormonal Effects: Potential interference with puberty and bone building Psychological Impact: Risk of trauma from the medicalization of body image Long-term Effects: Limited data on lifetime use starting in childhood Eating Disorders: Concerns from organizations like the Collaborative of Eating Disorders Organizations Some physicians have cried foul, arguing that the introduction of these medications during a period of significant growth and development could come with adverse health effects
What type of GLP-1 medication (semaglutide, tirzepatide, liraglutide) or other weight loss options do you think would work best for me and why
FDA Commissioner Marty Makary emphasized the agencys focus on preventing companies from bypassing the FDAs approval process through mass marketing of compounded drugs
According to a KFF analysis, as of November 2025, Rhode Island was one of only 13 states to cover GLP-1s for obesity through Medicaid
The mean weight loss among participants in its phase 1 trial was 13 percent of their starting body weight after 12 weeks